Physician profile
Ann Gage
NPI 1124319595
$22,208.39
in general payments reported to CMS, 2019-2025
35 companies · $3,134 in 2025
The $3,134 reported for 2025 was more than what 90% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2020: $65.25 · 2021: $671 · 2022: $2,594 · 2023: $9,146 · 2024: $6,248 · 2025: $3,134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $14K · Food and Beverage: $4,306 · Grant: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $14,000.00 |
| Food and Beverage | $4,306.27 |
| Grant | $222.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10,667.38 | 2020-2025 | Lifevest |
| Abiomed | $7,042.86 | 2022-2025 | Impella |
| Boston Scientific Corporation | $703.17 | 2020-2025 | Avvigo Guidance System, Ekosonic, Watchman Flx |
| Abbott Laboratories | $431.10 | 2019-2024 | Pressurewire, Optis, Thoratec Heartmate 3 Lvas Implant Kit |
| Pfizer INC. | $420.54 | 2021-2025 | |
| Getinge USA Sales, LLC | $362.04 | 2023-2024 | Cardiohelp, Base Unit Servo-U |
| Shockwave Medical, INC | $296.50 | 2021-2024 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $249.98 | 2019 | |
| Novo Nordisk INC | $242.59 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Inari Medical, INC. | $236.33 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Inquis Medical, INC. | $227.17 | 2024-2025 | Aventus |
| Edwards Lifesciences Corporation | $168.34 | 2022 | |
| Janssen Pharmaceuticals, INC | $166.50 | 2021-2022 | |
| Amgen INC. | $161.67 | 2021-2025 | |
| Teleflex LLC | $144.08 | 2023 | Arrow |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $138.08 | 2022-2024 | Azure Xt Dr Mri Surescan, Invos |
| Spectrawave, INC | $92.57 | 2025 | Starlight Imaging Catheter, Hypervue Imaging System |
| E.R. Squibb & Sons, L.L.C. | $80.72 | 2023-2024 | Camzyos, Eliquis |
| Angiodynamics, INC. | $58.39 | 2024-2025 | Alphavac |
| Penumbra, INC. | $41.54 | 2022-2023 | Indigo System |
| Novartis Pharmaceuticals Corporation | $33.26 | 2021-2022 | |
| Thrombolex, INC. | $25.35 | 2025 | Bashir Endovascular Catheter |
| Philips North America LLC | $24.66 | 2025 | Ecc Solutions |
| Inspire Medical Systems, INC. | $22.77 | 2023 | Inspire |
| Sanofi-Aventis U.S. LLC | $22.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $21.43 | 2019 | |
| Asahi Intecc USA, INC. | $19.66 | 2019 | |
| Alnylam Pharmaceuticals INC. | $18.69 | 2023 | Onpattro |
| Astrazeneca Pharmaceuticals LP | $18.65 | 2022 | |
| Zoll Circulation INC | $15.80 | 2023 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Cardiovascular Systems INC. | $15.30 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.20 | 2023 | Jardiance |
| Genzyme Corporation | $12.74 | 2022 | |
| Merck Sharp & Dohme LLC | $12.33 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Gage listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.